您的位置: 首页 > 2017年7月 第48卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

黄连素联合左氧氟沙星对肺炎克雷伯菌的体外抑菌研究

In vitro antibacterial effect of berberine on K. Pneunmoniae combing with levofloxacin

来源期刊: 广州医药 | 33-37 发布时间:2021-12-01 收稿时间:2025/11/13 17:10:45 阅读量:29
作者:
关键词:
黄连素左氧氟沙星肺炎克雷伯菌最低抑菌浓度生长曲线耐药突变选择窗
BerberineLevofloxacinK.pneunmoniae" style="padding-right:10px">K.pneunmoniae')">K.pneunmoniaeMICThe growth curveMSW
DOI:
10.3969/j.issn.1000-8535.2017.04.008
收稿时间:
2017-03-30 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨黄连素联合左氧氟沙星对肺炎克雷伯菌(KPn)抑菌作用。方法 KPn分为敏感株组和耐药株组,采用琼脂二倍稀释法测定黄连素联合左氧氟沙星对KPn的最低抑菌浓度(MIC)、抑制99%接种细菌生长的最低抑菌浓度(MIC99)、防突变浓度(MPC);比浊法测定黄连素联合左氧氟沙星对KPn生长曲线的影响。结果 与单用左氧氟沙星相比,联合黄连素后,敏感株组和耐药株组对左氧氟沙星MIC的下降率分别为33.3%和20%,2组之间无统计学差异(P>0.05)。左氧氟沙星与50 μg/mL黄连素或500 μg/mL黄连素联用后的抗菌能力均较单用左氧氟沙星好,且高浓度黄连素的联合抑菌效果较低浓度更加明显,差异有统计学意义(P<0.05)。与50 μg/mL黄连素联用后,左氧氟沙星SI下降了1/5 ;而与500 μg/mL黄连素联用则下降3/5 。结论 本实验证明了黄连素与左氧氟沙星联用能增加左氧氟沙星对KPn的抗菌作用,可以明显缩小耐药突变选择窗(MSW),且高浓度黄连素联合抗菌作用较低浓度好。
Objective To explore antibacterial effect of berberine(Ber) on K. Pneunmoniae(KPn) combing with levofloxacin(LVX). Methods KPn was divided into sensitive and resistant strains groups.The MIC, MIC99 and MPC of Ber combing with LVX on KPn was determined by the agar dilution method.The growth curve of Ber combing with LVX on KPn was measured by turbidimetry. Results Ber combined with LVX compare with LVX alone, MIC descent rate of sensitive strains group was 33.3%, resistant strains group was 20%, and there were no statistical differences along two groups(P>0.05). Ber combined with LVX could increase antibacterial effect and high concentration was more obvious than the low one, there were statistical differences(P<0.05). Compared with LVX alone,the SI value of 50 μg/mL Ber combined with LVX was decreased 1/5, and the SI value of 500 μg/mL Ber combined with LVX was decreased 3/5. Conclusion Ber combing with LVX could increase bacteriostatic effect on KPn,and reduce MSW significantly; high concentration of berberine was better than low one.
1、 STERMITZ F R, LORENZ P, TAWARA J N,et al. Synergy in a medicinal plant:antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor[J]. Proc Natl Acad Sci U S A, 2000, 97 (4): 1433-1437. STERMITZ F R, LORENZ P, TAWARA J N,et al. Synergy in a medicinal plant:antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor[J]. Proc Natl Acad Sci U S A, 2000, 97 (4): 1433-1437.
2、 XU Y, WANG Y, YAN L, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation[J]. J Proteome Res, 2009, 8 (11): 5296-5304. XU Y, WANG Y, YAN L, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation[J]. J Proteome Res, 2009, 8 (11): 5296-5304.
3、 FU H, LIU L G,PENG J P, et al. Transcriptional profile of the Shigella flexneri response to an alkaloid:berberine[J]. FEMS Microbiol Lett,2010,303(2):169-175. FU H, LIU L G,PENG J P, et al. Transcriptional profile of the Shigella flexneri response to an alkaloid:berberine[J]. FEMS Microbiol Lett,2010,303(2):169-175.
4、 KONG D X, LI X J, TANG G Y, et al. How many traditional Chinese medicine components have been recognized by modern Western medicine? A chemoinformatic analysis and implications for finding multicomponent drugs[J]. Chem Med Chem,2008,3(2): 233-236. KONG D X, LI X J, TANG G Y, et al. How many traditional Chinese medicine components have been recognized by modern Western medicine? A chemoinformatic analysis and implications for finding multicomponent drugs[J]. Chem Med Chem,2008,3(2): 233-236.
5、 胡付品, 朱德妹, 汪复,等.2013年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗志,2014,14(5): 365-374. 胡付品, 朱德妹, 汪复,等.2013年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗志,2014,14(5): 365-374.
6、 肖永红, 沈萍, 魏泽庆. Mohnarin 2011 年度全国细菌耐药监测[J]. 中华医院感染学杂志, 2012, 22(22): 4946-4952. 肖永红, 沈萍, 魏泽庆. Mohnarin 2011 年度全国细菌耐药监测[J]. 中华医院感染学杂志, 2012, 22(22): 4946-4952.
7、 STERMITZ F R, TAWARA-MATSUDA J, LORENZ P, et al. 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus[J]. J Nat Prod,2000, 63(8):1146-1149. STERMITZ F R, TAWARA-MATSUDA J, LORENZ P, et al. 5′-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus[J]. J Nat Prod,2000, 63(8):1146-1149.
8、 QUAN H, CAO Y Y, XU Z, et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole[J]. Antimicrob Agents Chemother, 2006,50(3):1096-1099. QUAN H, CAO Y Y, XU Z, et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole[J]. Antimicrob Agents Chemother, 2006,50(3):1096-1099.
9、 HAN Y, LEE J H. Berberine synergy with amphotericin B against disseminated candidiasis in mice[J].Biol Pharma Bull,2005,28(3): 541-544. HAN Y, LEE J H. Berberine synergy with amphotericin B against disseminated candidiasis in mice[J].Biol Pharma Bull,2005,28(3): 541-544.
10、 贾义军,岳枫. 肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J]. 医学信息,2013,8(13):77-78. 贾义军,岳枫. 肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J]. 医学信息,2013,8(13):77-78.
11、 杨秀云, 和建波, 郜俪薇, 等.医院感染病原菌的临床分布特征及耐药性分[J]. 中华医院感染学杂志, 2010,20(9):1313-1315. 杨秀云, 和建波, 郜俪薇, 等.医院感染病原菌的临床分布特征及耐药性分[J]. 中华医院感染学杂志, 2010,20(9):1313-1315.
12、 KO W C, DAVID L P, ANTHANASIA J S, et al. Community-acquired klebsiella pneumoniae bacteremia:global differences in clinical patterns[J]. Emerg Infect Dis,2002,8(2):160-166. KO W C, DAVID L P, ANTHANASIA J S, et al. Community-acquired klebsiella pneumoniae bacteremia:global differences in clinical patterns[J]. Emerg Infect Dis,2002,8(2):160-166.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录